The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Non-coding RNA in cancer
Open accessAbstract
Majority of the human genome is transcribed to RNAs that do not encode proteins. These non-coding RNAs (ncRNAs) play crucial roles in regulating the initiation and progression of various cancers. Given the importance of the ncRNAs, the roles of ncRNAs in cancers have been reviewed elsewhere. Thus, in this review, we mainly focus on the recent studies of the function, regulatory mechanism and therapeutic potential of the ncRNAs including microRNA (miRNA), long ncRNA (lncRNA), circular RNA (circRNA) and PIWI interacting RNA (piRNA), in different type of cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Li, Z., Zhang, J., Liu, X., Li, S., Wang, Q., Chen, D., Hu, Z., Yu, T., Ding, J., Li, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04006-0 · Cited by 217
RetractedNwaeburu, C. C., Abukiwan, A., Zhao, Z., & Herr, I. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0589-8 · Cited by 117
RetractedYu, B., You, W., Chen, G., Yu, Y., & Yang, Q. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1653107 · Cited by 26
RetractedYang, Y., Zhang, Y., Chen, B., Ding, L., Mu, Z., & Li, Y. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28916 · Cited by 25
RetractedFoxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2
Du, W. W., Yang, W., Liu, E., Yang, Z., Dhaliwal, P., & Yang, B. B. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw027 · Cited by 1,699
Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis
Zhou, W., Fong, M. Y., Min, Y., Somlo, G., Liu, L., Palomares, M. R., Yu, Y., Chow, A., O’Connor, S. T. F., Chin, A. R., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.007 · Cited by 1,476
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
Hong, D. S., Kang, Y.-K., Borad, M., Sachdev, J., Ejadi, S., Lim, H. Y., Brenner, A. J., Park, K., Lee, J.-L., Kim, T.-Y., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0802-1 · Cited by 975
Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity
Du, W. W., Fang, L., Yang, W., Wu, N., Awan, F. M., Yang, Z., & Yang, B. B. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2016.133 · Cited by 776
Long noncoding RNA MALAT1 suppresses breast cancer metastasis
Kim, J., Piao, H.-L., Kim, B.-J., Yao, F., Han, Z., Wang, Y., Xiao, Z., Siverly, A. N., Lawhon, S. E., Ton, B. N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0252-3 · Cited by 771
A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis
Zhang, M., Huang, N., Yang, X., Luo, J., Yan, S., Xiao, F., Chen, W., Gao, X., Zhao, K., Zhou, H., et al. (2018) · Oncogene · doi:10.1038/s41388-017-0019-9 · Cited by 721
Wang, Y., He, L., Du, Y., Zhu, P., Huang, G., Luo, J., Yan, X., Ye, B., Li, C., Xia, P., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.03.003 · Cited by 634
Wang, Z., Yang, B., Zhang, M., Guo, W., Wu, Z., Wang, Y., Jia, L., Li, S., Caesar-Johnson, S. J., Demchok, J. A., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.006 · Cited by 466
Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element
Cho, S. W., Xu, J., Sun, R., Mumbach, M. R., Carter, A. C., Chen, Y. G., Yost, K. E., Kim, J., He, J., Nevins, S. A., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.068 · Cited by 459
GUARDIN is a p53-responsive long non-coding RNA that is essential for genomic stability
Hu, W. L., Jin, L., Xu, A., Wang, Y. F., Thorne, R. F., Zhang, X. D., & Wu, M. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0066-7 · Cited by 347
Twist1 Regulates Vimentin through Cul2 Circular RNA to Promote EMT in Hepatocellular Carcinoma
Meng, J., Chen, S., Han, J.-X., Qian, B., Wang, X.-R., Zhong, W.-L., Qin, Y., Zhang, H., Gao, W.-F., Lei, Y.-Y., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3009 · Cited by 342
A circular RNA circ-DNMT1 enhances breast cancer progression by activating autophagy
Du, W. W., Yang, W., Li, X., Awan, F. M., Yang, Z., Fang, L., Lyu, J., Li, F., Peng, C., Krylov, S. N., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0369-y · Cited by 335
Malakar, P., Shilo, A., Mogilevsky, A., Stein, I., Pikarsky, E., Nevo, Y., Benyamini, H., Elgavish, S., Zong, X., Prasanth, K. V., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1508 · Cited by 317
Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis
Wang, X., Sun, W., Shen, W., Xia, M., Chen, C., Xiang, D., Ning, B., Cui, X., Li, H., Li, X., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.019 · Cited by 290
miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells
Lechman, E. R., Gentner, B., Ng, S. W. K., Schoof, E. M., van Galen, P., Kennedy, J. A., Nucera, S., Ciceri, F., Kaufmann, K. B., Takayama, N., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2015.12.011 · Cited by 268
Amodio, N., Stamato, M. A., Juli, G., Morelli, E., Fulciniti, M., Manzoni, M., Taiana, E., Agnelli, L., Cantafio, M. E. G., Romeo, E., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0067-3 · Cited by 260
Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression
Liang, G., Ling, Y., Mehrpour, M., Saw, P. E., Liu, Z., Tan, W., Tian, Z., Zhong, W., Lin, W., Luo, Q., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01152-2 · Cited by 260
Let‐7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer
Chirshev, E., Oberg, K. C., Ioffe, Y. J., & Unternaehrer, J. J. (2019) · Clinical and Translational Medicine · doi:10.1186/s40169-019-0240-y · Cited by 253
Hu, Z., Zhou, S., Li, J., Zhou, Z., Wang, P., Xin, H., Mao, L., Luo, C., Yu, S., Huang, X., et al. (2020) · Hepatology · doi:10.1002/hep.31068 · Cited by 252
Wei, Y., Chen, X., Liang, C., Ling, Y., Yang, X., Ye, X., Zhang, H., Yang, P., Cui, X., Ren, Y., et al. (2020) · Hepatology · doi:10.1002/hep.30795 · Cited by 244
Yan, H., Wu, Q.-L., Sun, C.-Y., Ai, L.-S., Deng, J., Zhang, L., Chen, L., Chu, Z.-B., Tang, B., Wang, K., et al. (2015) · Leukemia · doi:10.1038/leu.2014.135 · Cited by 233
Self-citationlnc-β-Catm elicits EZH2-dependent β-catenin stabilization and sustains liver CSC self-renewal
Zhu, P., Wang, Y., Huang, G., Ye, B., Liu, B., Wu, J., Du, Y., He, L., & Fan, Z. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3235 · Cited by 231
Kobayashi, M., Salomon, C., Tapia, J., Illanes, S. E., Mitchell, M. D., & Rice, G. E. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-4 · Cited by 225
Design of a small molecule against an oncogenic noncoding RNA
Velagapudi, S. P., Cameron, M. D., Haga, C. L., Rosenberg, L. H., Lafitte, M., Duckett, D. R., Phinney, D. G., & Disney, M. D. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523975113 · Cited by 218
Xu, Y., Leng, K., Yao, Y., Kang, P., Liao, G., Han, Y., Shi, G., Ji, D., Huang, P., Zheng, W., et al. (2021) · Hepatology · doi:10.1002/hep.31493 · Cited by 197
HOTTIP lncRNA Promotes Hematopoietic Stem Cell Self-Renewal Leading to AML-like Disease in Mice
Luo, H., Zhu, G., Xu, J., Lai, Q., Yan, B., Guo, Y., Fung, T. K., Zeisig, B. B., Cui, Y., Zha, J., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.10.011 · Cited by 192
Shi, Z., Zhang, J., Qian, X., Han, L., Zhang, K., Chen, L., Liu, J., Ren, Y., Yang, M., Zhang, A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0280 · Cited by 190
Zhu, Q., Lu, G., Luo, Z., Gui, F., Wu, J., Zhang, D., & Ni, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.119 · Cited by 189
LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer
Shi, Q., Li, Y., Li, S., Jin, L., Lai, H., Wu, Y., Cai, Z., Zhu, M., Li, Q., Li, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19349-w · Cited by 188
Anastasiadou, E., Seto, A. G., Beatty, X., Hermreck, M., Gilles, M.-E., Stroopinsky, D., Pinter‐Brown, L. C., Pestano, L. A., Marchese, C., Avigan, D., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3139 · Cited by 163
Li, X. L., Subramanian, M., Jones, M. F., Chaudhary, R., Singh, D. K., Zong, X., Gryder, B., Sindri, S., Mo, M., Schetter, A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.041 · Cited by 160
Bu, P., Wang, L., Chen, K.-Y., Srinivasan, T., Murthy, P. K. L., Tung, K.-L., Varanko, A. K., Chen, H. J., Ai, Y., King, S., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.01.006 · Cited by 158
Self-citationLuan, T., Zhang, X., Wang, S., Song, Y., Zhou, S., Lin, J., An, W., Yuan, W., Yang, Y., Cai, H., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19190 · Cited by 148
Su, W., Feng, S., Chen, X., Yang, X., Mao, R., Guo, C., Wang, Z., Thomas, D. G., Lin, J., Reddy, R. M., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0222 · Cited by 148
LncRNA H19 promotes glioma angiogenesis through miR-138/HIF-1α/VEGF axis
Liu, Z., Tian, Y., Wu, H., Ouyang, S. Y., & Kuang, W. (2019) · Neoplasma · doi:10.4149/neo_2019_190121n61 · Cited by 146
p53 Activates the Long Noncoding RNA Pvt1b to Inhibit Myc and Suppress Tumorigenesis
Olivero, C. E., Martínez-Terroba, E., Zimmer, J., Liao, C., Tesfaye, E., Hooshdaran, N., Schofield, J. A., Bendor, J., Fang, D., Simon, M. D., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2019.12.014 · Cited by 145
Li, B., Hong, J., Mei, H., Wang, Y., Yu, T., Zang, S., & Wu, Q. (2019) · Oncogene · doi:10.1038/s41388-019-0788-4 · Cited by 142
piR‐823 contributes to colorectal tumorigenesis by enhancing the transcriptional activity of HSF 1
Yin, J., Jiang, X., Qi, W., Ji, C., Xie, X., Zhang, D., Cui, Z., Wang, C., Bai, Y., Wang, J., et al. (2017) · Cancer Science · doi:10.1111/cas.13300 · Cited by 141
Jin, X., Xu, X., Jiang, Y., Liu, Y., Sun, W., Guo, Y.-J., Ren, Y.-X., Zuo, W., Hu, X., Huang, S.-L., et al. (2019) · Science Advances · doi:10.1126/sciadv.aat9820 · Cited by 137
miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT Signaling
Helou, R. E., Pinna, G., Cabaud, O., Wicinski, J., Bhajun, R., Guyon, L., Rioualen, C., Finetti, P., Gros, A., Mari, B. P., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.016 · Cited by 136
Su, Y., Wang, X., Mann, M., Adamus, T., Wang, D., Moreira, D., Zhang, Z., Ouyang, C., He, X., Zhang, B., et al. (2019) · Blood · doi:10.1182/blood.2019002045 · Cited by 135
The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling
Chen, B., Dragomir, M. P., Fabris, L., Bayraktar, R., Knutsen, E., Liu, X., Tang, C., Li, Y., Shimura, T., Ivković, T. C., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.08.018 · Cited by 134
Costales, M. G., Suresh, B. M., Vishnu, K., & Disney, M. D. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.04.008 · Cited by 133
Li, Z., Jin, C., Chen, S., Zheng, Y., Huang, Y., Jia, L., Ge, W., & Zhou, Y. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3015-z · Cited by 126
MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells
Ouzounova, M., Vuong, T., Ancey, P., Ferrand, M., Durand, G., Calvez‐Kelm, F. L., Croce, C. M., Matar, C., Herceg, Z., & Hernández‐Vargas, H. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-139 · Cited by 125
Hu, J. Y., Sun, T., Wang, H., Chen, Z., Wang, S., Yuan, L., Liu, T., Li, H., Wang, P., Feng, Y., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2015.12.005 · Cited by 125
MiR‐136 promotes apoptosis of glioma cells by targeting AEG‐1 and Bcl‐2
Yang, Y., Wu, J., Guan, H., Cai, J., Fang, L., Li, J., & Li, M. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.08.003 · Cited by 121
Role of let-7 family microRNA in breast cancer
Thammaiah, C. K., & Jayaram, S. (2016) · Non-coding RNA Research · doi:10.1016/j.ncrna.2016.10.003 · Cited by 114
Shao, C., Yang, F., Qin, Z., Jing, X., Shu, Y., & Shen, H. (2019) · BMC Cancer · doi:10.1186/s12885-019-6297-6 · Cited by 114
Cheng, C.-Y., Hwang, C., Corney, D. C., Flesken‐Nikitin, A., Jiang, L., Öner, M. G., Munroe, R. J., Schimenti, J. C., Hermeking, H., & Nikitin, A. Y. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.023 · Cited by 110
Role of HOTAIR long noncoding RNA in metastatic progression of lung cancer.
Zhao, W. M., An, Y., Liang, Y., & Xw, X. (2014) · PubMed · Cited by 109
Mai, D., Zheng, Y., Guo, H., Ding, P., Bai, R., Li, M., Ye, Y., Zhang, J., Huang, X., Liu, D., et al. (2020) · Theranostics · doi:10.7150/thno.46241 · Cited by 104
MaTAR25 lncRNA regulates the Tensin1 gene to impact breast cancer progression
Chang, K.-C., Diermeier, S. D., Yu, A. T., Brine, L., Russo, S., Bhatia, S., Alsudani, H., Kostroff, K. M., Bhuiya, T. A., Brogi, E., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20207-y · Cited by 100
Jin, B., Wang, W., Meng, X., Du, G., Li, J., Zhang, S.-Z., Zhou, B., & Fu, Z. (2016) · BMC Cancer · doi:10.1186/s12885-016-2904-y · Cited by 97
Lnc RNA H19 is associated with poor prognosis in breast cancer patients and promotes cancer stemness
Shima, H., Kida, K., Adachi, S., et al. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4793-z · Cited by 96
Expression and Functional Role of Reprogramming-Related Long Noncoding RNA (lincRNA-ROR) in Glioma
Feng, S., Yao, J., Chen, Y., Geng, P., Zhang, H., Ma, X., Zhao, J., & Yu, X. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0488-z · Cited by 93
Li, D., Fei, X.-R., Dong, Y., Cheng, C., Yang, Y., Deng, X., Huang, H.-L., Niu, W., Zhou, C.-X., Xia, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21513 · Cited by 90
Xia, C., Yang, Y., Kong, F., Kong, Q., & Shan, C. (2018) · Biochimie · doi:10.1016/j.biochi.2018.01.003 · Cited by 90
Wang, Y., Jiang, D., Hu, S., Zhao, L., Wang, L., Yang, M., Ai, M.-L., Jiang, H., Han, Y., Ding, Y., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2900 · Cited by 89
Özen, M., Karataş, Ö. F., Güllüoğlu, Ş., Karataş, Ö. F., Sevli, S., Güzel, E., Ekici, I. D., Çaşkurlu, T., Solak, M., Creighton, C. J., et al. (2015) · Cancer Investigation · doi:10.3109/07357907.2015.1025407 · Cited by 88
Shahabi, S., Kumaran, V., Castillo, J., Cong, Z., Nandagopal, G., Mullen, D. J., Alvarado, A., Correa, M. R., Saizan, A., Goel, R., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2034 · Cited by 86
Modulation of miRNA function by natural and synthetic RNA-binding proteins in cancer
Vos, P. D., Leedman, P. J., Filipovska, A., & Rackham, O. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03163-9 · Cited by 81
Circular RNA HIPK3 promotes glioma progression by binding to miR-124-3p
Hu, D., & Zhang, Y. (2018) · Gene · doi:10.1016/j.gene.2018.11.073 · Cited by 80
The MITF-SOX10 regulated long non-coding RNA DIRC3 is a melanoma tumour suppressor
Coe, E. A., Tan, J. Y., Shapiro, M., Louphrasitthiphol, P., Bassett, A. R., Marques, A. C., Goding, C. R., & Vance, K. W. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008501 · Cited by 78
miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells
Lechman, E. R., Gentner, B., Ng, S. W. K., Schoof, E. M., van Galen, P., Kennedy, J. A., Nucera, S., Ciceri, F., Kaufmann, K. B., Takayama, N., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.015 · Cited by 76
Li, J.-Z., Li, J., Wang, H., Li, X., Wen, B., & Wang, Y. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.045 · Cited by 76
Li, Y., & Disney, M. D. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00827 · Cited by 75
Choi, S. K., Kim, H., Jin, T.-F., Hwang, E. H., Jung, M., & Moon, W. (2016) · BMC Cancer · doi:10.1186/s12885-016-2620-7 · Cited by 74
Chen, D., Lu, X., Yang, F., & Xing, N. (2019) · Cancer Management and Research · doi:10.2147/cmar.s190669 · Cited by 73
Chen, Z., Zhao, H., Lin, L., Liu, J., Bai, J., & Wang, G. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13603 · Cited by 73
Li, Z., Lu, X., Liu, Y., Zhao, J., Ma, S., Yin, H., Huang, S., Zhao, Y., & He, X. (2020) · Hepatology · doi:10.1002/hep.31530 · Cited by 73
The tumor suppressor microRNA let-7 inhibits human LINE-1 retrotransposition
Tristán-Ramos, P., Rubio-Roldán, A., Peris, G., Sánchez, L., Amador‐Cubero, S., Viollet, S., Cristofari, G., & Heras, S. R. (2020) · Nature Communications · doi:10.1038/s41467-020-19430-4 · Cited by 72
Costales, M. G., Hoch, D. G., Abegg, D., Childs‐Disney, J. L., Velagapudi, S. P., Adibekian, A., & Disney, M. D. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b10558 · Cited by 70
The Molecular Basis and Therapeutic Potential ofLet-7MicroRNAs against Colorectal Cancer
Mizuno, R., Kawada, K., & Sakai, Y. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/5769591 · Cited by 68
MiR-126-3p inhibits ovarian cancer proliferation and invasion via targeting PLXNB2
Xiang, G., & Cheng, Y. (2018) · Reproductive Biology · doi:10.1016/j.repbio.2018.07.005 · Cited by 66
Yan, Y., Su, M., & Qin, B. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.01.055 · Cited by 65
Sharma, S., Pavlasová, G. M., Šeda, V., Černá, K. A., Vojáčková, E., Filip, D., Ondrišová, L., Šandová, V., Košťálová, L., Zeni, P. F., et al. (2021) · Blood · doi:10.1182/blood.2020005627 · Cited by 65
Role of miRNALet-7and Its Major Targets in Prostate Cancer
Wagner, S., Ngezahayo, A., Escobar, H. M., & Nolte, I. J. A. (2014) · BioMed Research International · doi:10.1155/2014/376326 · Cited by 61
MiR-155-5p positively regulates CCL17-induced colon cancer cell migration by targeting RhoA
Al-Haidari, A. A., Syk, I., & Thorlacius, H. (2017) · Oncotarget · doi:10.18632/oncotarget.14841 · Cited by 61
Feng, J., Yang, M., Wei, Q., Song, F., Zhang, Y., Wang, X., Liu, B., & Li, J. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15537 · Cited by 61
Roles of Mir-200 Family Members in Lung Cancer: More Than Tumor Suppressors
Liu, C., Hu, W., Li, L.-L., Wang, Y., Zhou, Q. Y., Zhang, F., Songyang, Y., Zhu, W., Sun, C., & Li, D. (2018) · Future Oncology · doi:10.2217/fon-2018-0155 · Cited by 60
Liu, N., Liu, Q., Yang, X., Zhang, F., Li, X., Ma, Y., Guan, F., Zhao, X., Li, Z., Zhang, L., et al. (2018) · Hepatology · doi:10.1002/hep.30098 · Cited by 57
Kimura, T. (2020) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.20-00002 · Cited by 57
Long non-coding RNA EPIC1 promotes human lung cancer cell growth
Zhang, B., Lu, H., Xia, Y., Jiang, A.-G., & Lv, Y.-X. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.07.046 · Cited by 56
Kennerdell, J. R., Liu, N., & Bonini, N. M. (2018) · Nature Communications · doi:10.1038/s41467-018-06592-5 · Cited by 56
Deregulation of miR-126 expression in colorectal cancer pathogenesis and its clinical significance
Ebrahimi, F., Gopalan, V., Wahab, R., Lu, C., Smith, R. A., & Lam, A. K.-Y. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.10.004 · Cited by 55
miR-99 regulates normal and malignant hematopoietic stem cell self-renewal
Khalaj, M., Woolthuis, C. M., Hu, W., Durham, B. H., Chu, S. H., Qamar, S., Armstrong, S. A., & Park, C. Y. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20161595 · Cited by 55
Huo, L., Wang, B., Zheng, M., Zhang, Y., Xu, J.-G., Yang, G., & Guan, Q. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7284 · Cited by 55
Targeting Long Noncoding RNA with Antisense Oligonucleotide Technology as Cancer Therapeutics
Zhou, T., Kim, Y., & MacLeod, A. R. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3378-5_16 · Cited by 54
Lin, H., Rothe, K., Chen, M., Wu, A., Babaian, A., Yen, R., Zeng, J., Rüschmann, J., Petriv, O. I., O’Neill, K., et al. (2020) · Blood · doi:10.1182/blood.2019003636 · Cited by 53
Fu, Q., Du, Y., Yang, C., et al. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2016.1181753 · Cited by 52
Wang, Y., Zhang, M., Xu, H., Wang, Y., Li, Z., Chang, Y., Wang, X., Fu, X., Zhou, Z., Yang, S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20053 · Cited by 52
Zhou, Q., Guo, J., Huang, W., Yu, X., Xu, C., & Long, X. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12700 · Cited by 52
PiwiRNA-651 as marker of treatment response and survival in classical Hodgkin lymphoma
Cordeiro, A., Navarro, A., Gayà, A., Díaz‐Beyá, M., González‐Farré, B., Castellano, J. J., Fuster, D., Martínez, C., Martínez, A., & Monzó, M. (2016) · Oncotarget · doi:10.18632/oncotarget.10015 · Cited by 49
Anandappa, G., Lampis, A., Cunningham, D., Khan, K. H., Kouvelakis, K., Vlachogiannis, G., Hedayat, S., Tunariu, N., Rao, S., Watkins, D. J., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3769 · Cited by 49
Wang, N., Yu, Y., Xu, B., Zhang, M., Li, Q., & Miao, L. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9721 · Cited by 48
ERINA Is an Estrogen-Responsive LncRNA That Drives Breast Cancer through the E2F1/RB1 Pathway
Fang, Z., Wang, Y., Wang, Z., Xu, M., Ren, S., Yang, D., Hong, M., & Xie, W. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1031 · Cited by 48
David, A., Zocchi, S., Talbot, A., Choisy, C., Ohnona, A., Lion, J., Cuccuini, W., Soulier, J., Arnulf, B., Bories, J.-C., et al. (2020) · Leukemia · doi:10.1038/s41375-020-01034-y · Cited by 47
Role of PIWI ‐interacting RNAs on cell survival: Proliferation, apoptosis, and cycle
Zeng, Q., Wan, H., Zhao, S., Xu, H., Tang, T., Agyare, O. K., & Qu, S. (2020) · IUBMB Life · doi:10.1002/iub.2332 · Cited by 46
Mao, Y., Lv, M., Cao, W., Liu, X., Cui, J., Wang, Y., Wang, Y., Nie, G., Liu, X., & Wang, H. (2020) · The FASEB Journal · doi:10.1096/fj.201903047r · Cited by 45
Li, Y., Zhang, H., Fan, L., Mou, J., Yin, Y., Peng, C., Chen, Y., Lu, H., Zhao, L., Tao, Z., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1228-1 · Cited by 44
Zang, H.-L., Li, Y., Zhang, X., & Huang, G. (2020) · Cancer Management and Research · doi:10.2147/cmar.s244024 · Cited by 44
Liu, Y., Jiang, Y., Xu, L., Qu, C., Zhang, L., Xiao, X., Chen, W., Li, K., Liang, Q., & Wu, H. (2020) · Cancer Management and Research · doi:10.2147/cmar.s245941 · Cited by 43
Xue, M., Hong, W., Jiang, J. H., Zhao, F., & Gao, X. (2020) · RNA Biology · doi:10.1080/15476286.2020.1789819 · Cited by 42
Prinz, C., & Weber, D. (2020) · Oncotarget · doi:10.18632/oncotarget.27520 · Cited by 40
miR-137: A Novel Therapeutic Target for Human Glioma
Wang, Y., Chen, R., Zhou, X., Guo, R., Yin, J., Li, Y., & Ma, G. (2020) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2020.06.028 · Cited by 40
Wang, S., Liu, F., Ma, H., Cui, X., Yang, S., & Qin, R. (2020) · Clinical Breast Cancer · doi:10.1016/j.clbc.2020.04.006 · Cited by 39
Ding, X., Zhang, J., Feng, Z., Tang, Q., & Zhou, X. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06518-6 · Cited by 39
Lovat, F., Nigita, G., Distefano, R., Nakamura, T., Gasparini, P., Tomasello, L., Fadda, P., Ibrahimova, N., Catricalà, S., Palamarchuk, A., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003597117 · Cited by 38
HOTAIR maintains the stemness of ovarian cancer stem cells via the miR-206/TBX3 axis
Zhang, Y., Guo, J., Cai, E., Cai, J., Wen, Y., Lu, S., Li, X., Han, Q., Jiang, J., Li, T., et al. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112218 · Cited by 38
Perdas, E., Stawski, R. S., Kaczka, K., & Zubrzycka, M. (2020) · Diagnostics · doi:10.3390/diagnostics10030130 · Cited by 37
Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
Chen, S.-R., Cai, W.-P., Dai, X.-J., Guo, A.-S., Chen, H.-P., Lin, G.-S., & Lin, R.-S. (2019) · PubMed · doi:10.26355/eurrev_201904_17711 · Cited by 37
Liu, Z., Guo, S., Sun, H., Bai, Y., Song, Z., & Liu, X. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.01013 · Cited by 35
MiR-766 induces p53 accumulation and G2/M arrest by directly targeting MDM4
Wang, Q., Selth, L. A., & Callen, D. F. (2017) · Oncotarget · doi:10.18632/oncotarget.15530 · Cited by 34
Han, B., Shaolong, E., Luan, L., Li, N., & Liu, X. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s251436 · Cited by 34
Zhou, J., Dong, Z.-N., Qiu, B., Hu, M., Liang, X.-Q., Dai, X., Hong, D., & Sun, Y. (2020) · Aging · doi:10.18632/aging.103388 · Cited by 33
Li, M., Pan, M., You, C., Zhao, F., Wu, D., Guo, M. L., Xu, H., Shi, F., Zheng, D., & Dou, J. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01264-z · Cited by 32
miR-22 Suppresses Tumor Invasion and Metastasis in Colorectal Cancer by Targeting NLRP3
Cong, J., Gong, J., Yang, C., Xia, Z., & Zhang, H. (2020) · Cancer Management and Research · doi:10.2147/cmar.s255125 · Cited by 32
The lncRNA XIST promotes the progression of breast cancer by sponging miR-125b-5p to modulate NLRC5.
Zong, Y., Zhang, Y., Hou, D., Xu, J., Cui, F., Qin, Y., & Sun, X. (2020) · PubMed · Cited by 32
Down-regulation of miR-342-3p in hepatocellular carcinoma tissues and its prognostic significance.
Gao, Y., Sg, Z., Wang, Z.-H., et al. (2017) · PubMed · Cited by 31
Qiu, Y., Xu, X.-P., Yin, X., & Peng, X. (2020) · Neoplasma · doi:10.4149/neo_2020_200106n17 · Cited by 31
Long non-coding RNA EPIC1 promotes cholangiocarcinoma cell growth
Li, Y., Cai, Q., Li, W., Feng, F., & Yang, L. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.174 · Cited by 30
Expression and correlation of miR‑124 and miR‑126 in breast cancer
Li, F. (2019) · Oncology Letters · doi:10.3892/ol.2019.10184 · Cited by 30
Li, X., Xia, D., Cong, S., et al. (2018) · PubMed · doi:10.26355/eurrev_201812_16533 · Cited by 30
Long Non-coding RNA EPIC1 Promotes Cell Proliferation and Motility and Drug Resistance in Glioma
Wang, J., Yang, S., Ji, Q., et al. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.03.011 · Cited by 30
Xia, P., Liu, P., Fu, Q., Liu, C., Luo, Q., Zhang, X., Cheng, L., Qin, T., & Zhang, H. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.11.167 · Cited by 29
Circ_DCAF6 potentiates cell stemness and growth in breast cancer through GLI1-Hedgehog pathway
Ye, G., Pan, R., Zhu, L., & Zhou, D. (2020) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2020.104492 · Cited by 29
Knockdown of the long noncoding RNA XIST suppresses glioma progression by upregulating miR-204-5p
Shen, J., Xiong, J., Shao, X., Cheng, H., Fang, X., Sun, Y., Di, G., Mao, J., & Jiang, X. (2020) · Journal of Cancer · doi:10.7150/jca.45676 · Cited by 28
Xiong, S., Li, D., Wang, D., Huang, L., Liang, G., Wu, Z., Long, J., Yang, D., Teng, Y., Lei, S., et al. (2020) · Cancer Management and Research · doi:10.2147/cmar.s257386 · Cited by 28
miR-93-5p suppresses cellular senescence by directly targeting Bcl-w and p21
Choi, J. Y., Shin, H. J., & Bae, I. H. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.10.010 · Cited by 27
Fu, Y., Su, L., Cai, M., Yao, B., Xiao, S., He, Q., Xu, L., Yang, L., Zhao, C., Wan, T., et al. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.23095 · Cited by 27
Wang, N., Cao, Q., Tian, J., Ren, L., Cheng, H., & Yang, S.-Q. (2020) · Cell Transplantation · doi:10.1177/0963689720943613 · Cited by 27
SCIRT lncRNA Restrains Tumorigenesis by Opposing Transcriptional Programs of Tumor-Initiating Cells
Zagorac, S., de Giorgio, A., Dabrowska, A. F., Kalisz, M., Casas-Vila, N., Cathcart, P. J., Yiu, A., Ottaviani, S., Degani, N., Lombardo, Y., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-2612 · Cited by 26
Nweke, E. E., & Brand, M. (2020) · Oncology Letters · doi:10.3892/ol.2020.11854 · Cited by 25
Circular RNA-0001283 Suppresses Breast Cancer Proliferation and Invasion via MiR-187/HIPK3 Axis
Hu, Y., Guo, F., Zhu, H., Tan, X., Zhu, X., Liu, X., Zhang, W., Yang, Q., & Jiang, Y. (2020) · Medical Science Monitor · doi:10.12659/msm.921502 · Cited by 23
In vivo miRNA knockout screening identifies miR-190b as a novel tumor suppressor
Hong, H., Yao, S., Zhang, Y., Ye, Y., Li, C., Hu, L., Sun, Y., Huang, H., & Ji, H. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1009168 · Cited by 23
MicroRNA-155 contributes to plexiform neurofibroma growth downstream of MEK
Na, Y., Hall, A., Choi, K., Hu, L., Rose, J., Coover, R. A., Miller, A., Hennigan, R. F., Dombi, E., Kim, M., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01581-9 · Cited by 23
Chang, S., Sun, G., Zhang, D., Li, Q., Wan, Y., Zhou, X., Lu, Q., Han, X., Chen, X., Xing, T., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02789-z · Cited by 21
HIF-miR-215-KDM1B promotes glioma-initiating cell adaptation to hypoxia
Hu, J. Y., & Wang, X. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1181877 · Cited by 14
Mi, L., Lei, L., Yin, X., Li, N., Shi, J., Han, X., Duan, X., Zhao, M., Han, G., Wang, J., et al. (2020) · Bioscience Reports · doi:10.1042/bsr20201313 · Cited by 9
Cited by
Understanding the role of the gut microbiome in gastrointestinal cancer: A review
Ağagündüz, D., Cocozza, E., Cemali, Ö., Bayazıt, A. D., Nanì, M. F., Cerqua, I., Morgillo, F., Saygılı, S. K., Berni Canani, R., Amero, P., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1130562 · Cited by 189
Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer
Gu, Y., Yang, R., Zhang, Y., Guo, M., Takehiro, K., Zhan, M., Yang, L., & Wang, H. (2025) · Molecular Biomedicine · doi:10.1186/s43556-024-00239-2 · Cited by 184
Epigenetic modifications: Key players in cancer heterogeneity and drug resistance
Sadida, H. Q., Abdulla, A., Marzooqi, S. A., Hashem, S., Macha, M. A., Akil, A. S. A.-S., & Bhat, A. A. (2024) · Translational Oncology · doi:10.1016/j.tranon.2023.101821 · Cited by 151
Cao, L., Wang, Y., Liu, J., Bai, X., & Chi, X. (2024) · American Journal of Reproductive Immunology · doi:10.1111/aji.13864 · Cited by 7
Metadata
- Authors
- Yan, H., & Bu, P.
- Venue
- Essays in Biochemistry
- Publisher
- Portland Press Ltd.
- Published
- 2021-10
- Volume
- 65
- Issue
- 4
- Pages
- 625-639
- ISSN
- 0071-1365 (ISSN-L)
- 1744-1358
- OpenAlex
- W3153642798
- Cited by
- 667
- References
- 144
- FWCI
- 31.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.